Hypoglycemic composition containing rumex hanus as well as preparation method and application of hypoglycemic composition

A multi-component compound composition was prepared by scientifically combining edible grass with 13 kinds of plant extracts, which solved the problems of large side effects and single ingredients of existing blood sugar-lowering products, and achieved significant blood sugar-lowering effects and high safety through multi-target regulation.

CN120789171APending Publication Date: 2025-10-17BEIJING HEMU RUNFENG ECOLOGICAL FARM
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202510921983.0
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2025-07-04
Publication Date
2025-10-17

AI Technical Summary

Technical Problem

The existing blood sugar lowering products on the market have problems such as large side effects, single ingredients, insufficient synergy, and insignificant blood sugar lowering effects, making it difficult to achieve multi-target regulation of blood sugar.

Method used

Using edible grass as the core ingredient and combining it with 13 kinds of plant extracts, including white kidney bean and arabinose, a multi-component compound composition is prepared through ethanol extraction and spray drying process, which is used to prepare functional foods or medical health products for lowering blood sugar.

Benefits of technology

It achieves a multi-target synergistic effect in lowering blood sugar, taking into account both postprandial blood sugar control and fasting blood sugar regulation, improving insulin resistance and pancreatic cell function, with high safety and a 20% increase in the yield of active ingredients.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN120789171A_ABST
    Figure CN120789171A_ABST
Patent Text Reader

Abstract

The invention discloses a blood sugar reducing composition containing rumex hanus as well as a preparation method and application thereof, and the blood sugar reducing composition containing rumex hanus is prepared from the following raw materials in parts by weight: 19 to 21 parts of rumex hanus extract, 29 to 31 parts of white kidney bean extract, 8 to 10 parts of arabinose and 30.4 to 49.6 parts of auxiliary components. The invention relates to a preparation method and application of a hypoglycemic composition containing rumex hanus. According to the hypoglycemic composition based on the theory of homology of medicine and food provided by the invention, various plant extracts are scientifically proportioned to play a synergistic effect, so that a multi-way hypoglycemic effect of inhibiting exogenous sugar absorption, regulating endogenous sugar metabolism, improving pancreas islet function and resisting oxidative damage is realized; the composition has the advantages of high safety, small side effect, lasting effect and the like.
Need to check novelty before this filing date? Find Prior Art

Description

TECHNICAL FIELD

[0001] The present application relates to a composition and its preparation method and application, and particularly relates to a blood glucose lowering composition containing Rumex vesicarius L and its preparation method and application. BACKGROUND

[0002] Diabetes is a global high-incidence metabolic disease characterized by high blood sugar, which seriously threatens human health. Plant extracts are a research hotspot for blood glucose lowering functional foods and drugs due to their natural and low toxicity. Rumex vesicarius L is rich in active ingredients such as protein, polyphenol and flavonoid. Studies have shown that it has the effects of regulating glucose and lipid metabolism and antioxidant activity. White kidney bean extract contains alpha-amylase inhibitors, which can inhibit the decomposition of starch into glucose. Medicinal and edible plants such as Pueraria lobata, Morus alba and Polygonatum sibiricum are often used in traditional medicine for the treatment of diabetes. Modern research has confirmed that they have the effects of improving insulin sensitivity and promoting glucose utilization.

[0003] At present, the main blood glucose lowering products on the market are mainly western medicines (such as metformin and insulin), which have the advantages of fast effect but have side effects such as liver and kidney damage and the risk of hypoglycemia when taken for a long time. Although traditional Chinese medicine compounds or plant extract products have fewer side effects, they generally have the problems of single formula composition, insufficient synergistic effect, insignificant blood glucose lowering effect or unclear mechanism of action, and some products rely on a single active ingredient (such as puerarin and white kidney bean extract), which makes it difficult to achieve multi-target regulation of blood glucose (such as inhibiting sugar absorption, improving insulin resistance and repairing islet cells). SUMMARY

[0004] In order to solve the above technical problems, the present application provides a blood glucose lowering composition containing Rumex vesicarius L and its preparation method and application.

[0005] In order to solve the above technical problems, the present application adopts the technical scheme of a blood glucose lowering composition containing Rumex vesicarius L, which comprises the following raw materials in parts by weight: Rumex vesicarius L extract 19-21 parts, white kidney bean extract 29-31 parts, arabinose 8-10 parts and auxiliary ingredients 30.4-49.6 parts.

[0006] Preferably, the auxiliary ingredients comprise the following raw materials in parts by weight: pumpkin seed extract 1-3 parts, Pueraria lobata extract 5-7 parts, Morus alba extract 3-5 parts, Polygonatum sibiricum extract 4-5 parts, Eucommia ulmoides male flower extract 1-3 parts, Cassia seed extract 3.0-3.4 parts, Dioscorea opposita extract 4-6 parts, Glycyrrhiza extract 1.2-1.6 parts, Polygonatum odoratum extract 3-5 parts, Tricholoma matsutake extract 3-5 parts, Gigeria pigon extract 1-3 parts, Medlar seed extract 0.5-1.5 parts and Fructus Corni extract 0.7-1.1 parts.

[0007] Preferably, the raw materials include the following parts by weight: Herba Phyllodium extract 20 parts, white kidney bean extract 30 parts, pumpkin seed extract 2 parts, Pueraria extract 6 parts, mulberry leaf extract 4 parts, Rhizoma Polygonati extract 4.5 parts, Eucommia flower extract 2 parts, Cassia seed extract 3.2 parts, Dioscorea extract 5 parts, licorice extract 1.4 parts, Polygonatum extract 4 parts, Hericium extract 4 parts, chicken gizzard extract 2 parts, Chinese wolfberry extract 1.0 part, Cornus extract 0.9 part, and arabinose 10 parts.

[0008] A preparation method of a blood sugar-lowering composition containing Herba Phyllodium, comprising the following steps: I. Measuring the ingredients: measuring the above-mentioned raw materials according to the ratio in turn; II. Pretreatment of the raw materials: grinding the plant raw materials in turn, mixing according to the ratio, and then extracting twice with an ethanol solution in a water bath, each time for 1-2 hours, and combining the extract; III. Concentration and drying: concentrating the extract under reduced pressure to extract residue, and spray drying to obtain powder; IV. Mixing and homogenization: mixing the dried powder with arabinose according to the formula ratio, passing through a 75-85 mesh sieve, and homogenizing for 25-35 minutes using a three-dimensional motion mixer to obtain the composition.

[0009] Preferably, in step II, the raw materials are ground to 35-45 mesh, the volume fraction of the ethanol solution is 60%, the mass ratio of the raw materials to the ethanol solution is 1:10, and the water bath temperature is 55-65℃.

[0010] Preferably, in step III, the temperature for reduced pressure concentration is 40-50℃, the vacuum degree is 0.06-0.1 MPa, the inlet air temperature is 170-190℃, and the outlet air temperature is 75-85℃.

[0011] The application of a blood sugar-lowering composition containing Herba Phyllodium, which is used to prepare a blood sugar-lowering functional food or a medical health product.

[0012] Compared with the prior art, the present application has the following beneficial effects: 1) For the first time, Herba Phyllodium is used as the core component, combined with 13 kinds of auxiliary components, to form a full-natural multi-component compound, breaking through the limitations of single components; 2) Significant effect: achieving blood sugar-lowering through the multi-target synergistic effect of "inhibiting sugar absorption-regulating sugar metabolism-protecting islet cells"; multi-component synergistic effect, taking into account postprandial blood glucose control and fasting blood glucose regulation, while improving insulin resistance and islet cell function; 3) High safety: no chemical synthetic components, low toxicity and side effects, suitable for long-term use; 4) Preparation optimization: the preparation method of ethanol extraction combined with spray drying ensures efficient retention of active ingredients, and the extraction process parameters (temperature, time, ethanol concentration) are optimized by orthogonal test, and the yield of active ingredients is increased by 20% compared with traditional methods. BRIEF DESCRIPTION OF DRAWINGS

[0013] Figure 1 The preparation flowchart of the present application is shown in the figure. Figure 2 The efficacy experiment results of the present application are shown in the figure. DETAILED DESCRIPTION

[0014] The present application will be further described in detail below in combination with the drawings and specific embodiments.

[0015] Example 1 A blood glucose lowering composition containing Shiyecao, including the following formula amount of raw materials: Shiyecao extract 19g, white kidney bean extract 29g, arabinose 8g, pumpkin seed extract 1g, Gegen extract 5g, mulberry leaf extract 3g, Huangjing extract 4g, Eucommia ulmoides male flower extract 1g, Cassia seed extract 3.0g, yam extract 4g, licorice extract 1.2g, Polygonatum extract 3g, Agaricus blazei extract 3g, chicken gizzard suet extract 1g, medlar fruit extract 0.5g, and Euonymus extract 0.7g.

[0016] A preparation method of a blood glucose lowering composition containing Shiyecao, including the following steps: I. Weighing ingredients: weighing the above-mentioned raw materials in turn according to the proportion; II. Pretreatment of raw materials: grinding the plant raw materials in turn, mixing according to the proportion, and then extracting twice with ethanol solution in water bath, each time for 1 hour, and combining the extract; grinding the raw materials to 35 mesh, the volume fraction of ethanol solution is 60%, and the mass ratio of raw materials to ethanol solution is 1:10, and the water bath temperature is 55℃.

[0017] III. Concentration and drying: concentrating the extract to extractum under reduced pressure, and spray drying to obtain powder; the temperature of reduced pressure concentration is 40℃, the vacuum degree is 0.06MPa, the inlet air temperature is 170℃, and the outlet air temperature is 75℃.

[0018] IV. Mixing and homogenization: mixing the dried powder with arabinose according to the formula proportion, passing through a 75 mesh sieve, and homogenizing for 25 minutes with a three-dimensional motion mixer to obtain the composition.

[0019] The composition can be used for preparing blood glucose lowering functional foods (such as tablets, capsules, and granules) or medical and health care products, and is suitable for blood glucose auxiliary regulation of pre-diabetic population and type 2 diabetes patients.

[0020] As the core ingredient, the extract of Euphorbia helioscopia L. is rich in polyphenols and flavonoids, which can regulate the activity of sugar metabolism enzymes, improve insulin resistance, and protect pancreatic β cells. The extract of Phaseolus lunatus L. contains α-amylase inhibitors, which can inhibit starch digestion and absorption, and reduce postprandial blood glucose fluctuations. The extract of Cucurbita pepo L. provides essential fatty acids and zinc elements, which can help regulate insulin secretion. The extract of Pueraria lobata Ohwi promotes glucose transport and improves microcirculation through puerarin, relieving diabetic vascular complications. 1-deoxynojirimycin (DNJ) in the extract of Morus alba L. can inhibit α-glucosidase and delay sugar absorption. The polysaccharide component of the extract of Polygonatum sibiricum Redoute enhances insulin sensitivity and promotes hepatic glycogen synthesis. The extract of Eucommia ulmoides Oliv. regulates adrenaline secretion and inhibits stress-induced blood glucose rise. The anthraquinone component of the extract of Cassia obtusifolia L. improves lipid metabolism and reduces obesity-related insulin resistance. The mucin in the extract of Dioscorea opposita Thunb. protects the gastric mucosa, delays sugar absorption, and at the same time, invigorates the spleen and replenishes qi, improving the symptoms of diabetes. The glycyrrhizic acid in the extract of Glycyrrhiza uralensis Fisch. regulates inflammatory factors and reduces inflammatory damage to pancreatic cells. The polysaccharide in the extract of Polygonatum odoratum Druce promotes the proliferation of pancreatic β cells and enhances insulin secretion capacity. The extract of Agaricus blazei Murill contains β-glucan, which regulates intestinal flora and improves the function of the intestinal-pancreatic axis. The extract of Galla Rhois can promote digestion and absorption, and help regulate sugar metabolism. The polysaccharide in the extract of Lycium barbarum L. enhances antioxidant capacity and reduces high-sugar-induced oxidative damage. The iridoid component in the extract of Fructus Corni Cirrhosae inhibits renal glucose reabsorption and promotes sugar excretion. Arabinose can inhibit intestinal sucrase activity and reduce the decomposition of sucrose into glucose.

[0021] The extract of Euphorbia helioscopia L. (core ingredient), the extract of Phaseolus lunatus L. (key auxiliary ingredient), and arabinose (synergistic sugar absorption inhibitor) are indispensable; the remaining ingredients are auxiliary ingredients that can optimize the synergistic effect.

[0022] Each component synergistically reduces blood sugar through multiple pathways: 1) Inhibition of exogenous sugar absorption: the extract of Phaseolus lunatus L. inhibits α-amylase, and arabinose inhibits sucrase, both of which reduce glucose production. 2) Regulation of endogenous sugar metabolism: the extracts of Euphorbia helioscopia L., Polygonatum sibiricum Redoute, and Polygonatum odoratum Druce enhance insulin sensitivity, promote glucose transport, and stimulate hepatic glycogen synthesis. 3) Protect the function of islets: flavonoids of food leaves, polysaccharides of medlar resist oxidation, reduce the damage of high sugar to islet beta cells, adjust the sugar excretion of intestines and kidneys by tricholoma mongolicum and cornus officinalis; The application provides a blood sugar reducing composition based on the theory of medicinal food homology, and has the advantages of high safety, small side effect, long effect and the like by scientific proportioning of various plant extracts, synergistic effect, inhibition of exogenous sugar absorption, regulation of endogenous sugar metabolism, improvement of islet function and anti-oxidation damage.

[0023] Example 2 A blood sugar reducing composition containing food leaves, including the following formula amount of raw materials: food leaf extract 21g, white kidney bean extract 31g, arabinose 10g, pumpkin seed extract 3g, radix puerariae extract 7g, mulberry leaf extract 5g, polygonatum extract 5g, eucommia bud extract 3g, cassia seed extract 3.4g, yam extract 6g, licorice extract 1.6g, polygonatum odoratum extract 5g, tricholoma mongolicum extract 5g, chicken gizzard suet extract 3g, medlar extract 1.5g, cornus officinalis extract 1.1g.

[0024] A preparation method of a blood sugar reducing composition containing food leaves, including the following steps: I. Weighing ingredients: weigh the above-mentioned raw materials according to the proportion in turn; II. Raw material pretreatment: grind the plant raw materials in turn, mix them according to the proportion, extract them twice with ethanol solution in water bath for 2 hours each time, and combine the extract; grind the raw materials to 45 meshes, the volume fraction of ethanol solution is 60%, the mass ratio of raw materials to ethanol solution is 1:10, and the water bath temperature is 65℃.

[0025] III. Concentration and drying: concentrate the extract to extractum under reduced pressure, and spray dry the extractum to obtain powder; the temperature of reduced pressure concentration is 50℃, the vacuum degree is 0.1MPa, the inlet air temperature is 190℃, and the outlet air temperature is 85℃.

[0026] IV. Mixing and homogenizing: mix the dry powder with arabinose according to the formula proportion, pass them through a 85-mesh sieve, and homogenize them with a three-dimensional motion mixer for 35 minutes to obtain the composition.

[0027] Example 3 A blood sugar reducing composition containing food leaves, including the following formula amount of raw materials: food leaf extract 20g, white kidney bean extract 30g, pumpkin seed extract 2g, radix puerariae extract 6g, mulberry leaf extract 4g, polygonatum extract 4.5g, eucommia bud extract 2g, cassia seed extract 3.2g, yam extract 5g, licorice extract 1.4g, polygonatum odoratum extract 4g, tricholoma mongolicum extract 4g, chicken gizzard suet extract 2g, medlar extract 1.0g, cornus officinalis extract 0.9g, arabinose 10g.

[0028] A preparation method of a blood sugar reducing composition containing food leaf grass, comprising the following steps: I. Weighing ingredients: weighing the above-mentioned raw materials in turn according to the proportion; II. Pretreatment of raw materials: crushing the plant raw materials in turn, mixing according to the proportion, and then extracting twice with ethanol solution water bath, each time for 1.5 hours, and combining the extract; crushing the raw materials to 40 mesh, the volume fraction of ethanol solution is 60%, the mass ratio of raw materials to ethanol solution is 1:10, and the water bath temperature is 60℃.

[0029] III. Concentration and drying: concentrating the extract under reduced pressure to extract residue, and spray drying to obtain powder; the temperature of reduced pressure concentration is 45℃, the vacuum degree is 0.08MPa, the inlet air temperature is 180℃, and the outlet air temperature is 80℃.

[0030] IV. Mixing and homogenization: mixing the dry powder with arabinose according to the formula proportion, passing through an 80-mesh sieve, and homogenizing for 30 minutes with a three-dimensional motion mixer to obtain the composition.

[0031] Example 4 A blood sugar reducing composition containing food leaf grass, comprising the following formula amount of raw materials: food leaf grass extract 19g, white kidney bean extract 29g, arabinose 8g, pumpkin seed extract 1g, kudzu root extract 5g, mulberry leaf extract 3g, yellow ginseng extract 4g, eucommia bark extract 1g, cassia seed extract 3.1g, yam extract 4g, licorice extract 1.3g, polygonatum extract 3g, shiitake mushroom extract 3g, chicken gizzard extract 1g, medlar fruit extract 0.7g, and dogwood extract 0.8g.

[0032] A preparation method of a blood sugar reducing composition containing food leaf grass, comprising the following steps: I. Weighing ingredients: weighing the above-mentioned raw materials in turn according to the proportion; II. Pretreatment of raw materials: crushing the plant raw materials in turn, mixing according to the proportion, and then extracting twice with ethanol solution water bath, each time for 1.5 hours, and combining the extract; crushing the raw materials to 40 mesh, the volume fraction of ethanol solution is 60%, the mass ratio of raw materials to ethanol solution is 1:10, and the water bath temperature is 60℃.

[0033] III. Concentration and drying: concentrating the extract under reduced pressure to extract residue, and spray drying to obtain powder; the temperature of reduced pressure concentration is 45℃, the vacuum degree is 0.08MPa, the inlet air temperature is 180℃, and the outlet air temperature is 80℃.

[0034] IV. Mixing and homogenization: mixing the dry powder with arabinose according to the formula proportion, passing through an 80-mesh sieve, and homogenizing for 30 minutes with a three-dimensional motion mixer to obtain the composition.

[0035] Example 5 A blood sugar reducing composition containing food leaf grass, comprising the following formula amount of raw materials: food leaf grass extract 21g, white kidney bean extract 31g, arabinose 10g, pumpkin seed extract 3g, kudzu root extract 7g, mulberry leaf extract 5g, polygonatum extract 5g, eucommia male flower extract 3g, cassia seed extract 3.3g, yam extract 6g, licorice extract 1.5g, polygonatum extract 5g, chaga mushroom extract 5g, chicken gizzard extract 3g, medlar fruit extract 1.3g, and dogwood extract 1g.

[0036] A preparation method of a blood sugar reducing composition containing food leaf grass, comprising the following steps: I. Weighing ingredients: weighing the above-mentioned raw materials according to the ratio in turn; II. Pretreatment of raw materials: grinding the plant raw materials in turn, mixing according to the ratio, and then extracting twice with ethanol solution in water bath, each for 2 hours, and combining the extract; grinding the raw materials to 43 mesh, the volume fraction of ethanol solution is 60%, the mass ratio of raw materials to ethanol solution is 1:10, and the water bath temperature is 63℃.

[0037] III. Concentration and drying: concentrating the extract under reduced pressure to extract, and spray drying to obtain powder; the temperature of reduced pressure concentration is 48℃, the vacuum degree is 0.09MPa, the inlet air temperature is 185℃, and the outlet air temperature is 83℃.

[0038] IV. Mixing and homogenizing: mixing the dry powder with arabinose according to the formula ratio, passing through a 83 mesh sieve, and homogenizing for 33 minutes with a three-dimensional motion mixer to obtain the composition.

[0039] Example 6 A blood sugar reducing composition containing food leaf grass, comprising the following formula amount of raw materials: food leaf grass extract 20g, white kidney bean extract 30g, arabinose 9g, pumpkin seed extract 2g, kudzu root extract 6g, mulberry leaf extract 4g, polygonatum extract 4.5g, eucommia male flower extract 2g, cassia seed extract 3.3g, yam extract 5g, licorice extract 1.4g, polygonatum extract 4g, chaga mushroom extract 4g, chicken gizzard extract 2g, medlar fruit extract 1g, and dogwood extract 0.9g.

[0040] The preparation method of this example is the same as that of example 1.

[0041] The effect of relieving symptoms of alcoholism of the application was detected by example 1.

[0042] 1. Detection principle Zebrafish and humans have some similarities in sugar metabolism. When zebrafish are given a high-sugar environment, their blood glucose regulation mechanism is challenged. A large amount of sugar intake exceeds the normal glucose uptake and utilization capacity of zebrafish. Under normal circumstances, cells take up glucose through insulin-mediated signaling pathways and use it for energy production or conversion to glycogen storage. However, under high-sugar conditions, excessive glucose can lead to increased insulin secretion, but long-term high-sugar stimulation can reduce insulin sensitivity, i.e., the response of cells to insulin, resulting in reduced glucose uptake. In addition, a high-sugar environment can damage pancreatic islet cells, affecting insulin synthesis and secretion, impairing blood glucose regulation, and causing blood glucose levels to rise, ultimately forming a hyperglycemia model, and the positive drug metformin.

[0043] 2. Materials and methods 2.1 Experimental instruments and reagents: centrifuge, ultrasonic cell disruptor, Roche blood glucose meter, glucose, metformin.

[0044] 2.2 Detection system and sample size Experimental system: wild AB strain zebrafish; Zebrafish age: 1 day after fertilization; Sample size per group: 30 fish per group in one well; Juvenile fish feeding and breeding method: according to the standard feeding and breeding method of the company.

[0045] 3. Experimental procedure The zebrafish to be tested were divided into four groups, namely the normal control group, the model control group, the positive control group and the sample treatment group. The normal control group was not treated, the model control group was established in a high-sugar environment, the positive control group was added with metformin while establishing a high-sugar environment, and the sample treatment group was added with the sample to be tested while establishing a high-sugar environment. After a period of culture, the four groups of zebrafish were crushed and centrifuged to obtain the supernatant, the blood glucose was measured, and the results of the four groups were compared and analyzed. For the detection of the auxiliary blood glucose lowering effect of health products, food and their raw materials, the sample should be dissolved in water or prepared into a uniform suspension in water.

[0046] On the basis of meeting the effectiveness of the test, the blood glucose value of the model control group was significantly increased compared with the blank control group (P<0.05), indicating that the modeling was successful. The blood glucose value of the sample treatment group was significantly reduced compared with the model control group (P<0.05), indicating that the sample had an auxiliary blood glucose lowering effect.

[0047] Pre-experiment detection results: there was no significant difference between the sample group at a concentration of 500 μg / mL and the blank control group, so the concentration of 500 μg / mL is the maximum safe concentration.

[0048] The results of the detection (see the table below):

[0049] Zebrafish blood glucose value (mmol / L)

[0050] The column chart of the sample efficacy experiment results is shown in the following figure: Figure 2 Among them, *: P < 0.05; **: P < 0.01; ***: P < 0.001; the more stars, the smaller the P value represents the more significant the difference.

[0051] The above embodiments are not a limitation on the present application, and the present application is also not limited to the above examples. Changes, modifications, additions or substitutions made by those skilled in the art within the scope of the technical solutions of the present application also belong to the protection scope of the present application.​

Claims

1. A blood sugar lowering composition containing edible leaves, characterized in that: The invention comprises the following raw materials in parts by weight: 19-21 parts of phyllostachys serrata extract, 29-31 parts of white kidney bean extract, 8-10 parts of arabinose and 30.4-49.6 parts of auxiliary components.

2. The blood sugar lowering composition containing edible leaves according to claim 1, characterized in that: The auxiliary components include the following raw materials in parts by weight: 1-3 parts of pumpkin seed extract, 5-7 parts of kudzu root extract, 3-5 parts of mulberry leaf extract, 4-5 parts of polygonatum extract, 1-3 parts of eucommia male flower extract, 3.0-3.4 parts of cassia seed extract, 4-6 parts of yam extract, 1.2-1.6 parts of licorice extract, 3-5 parts of polygonatum extract, 3-5 parts of agaricus blazei extract, 1-3 parts of chicken gizzard lining extract, 0.5-1.5 parts of wolfberry extract, and 0.7-1.1 parts of cornus officinalis extract.

3. The blood sugar lowering composition containing edible leaves according to claim 2, characterized in that: The invention comprises the following raw materials in parts by weight: 20 parts of ophiopogon extract, 30 parts of white kidney bean extract, 2 parts of pumpkin seed extract, 6 parts of kudzu root extract, 4 parts of mulberry leaf extract, 4.5 parts of polygonatum extract, 2 parts of eucommia male flower extract, 3.2 parts of cassia seed extract, 5 parts of yam extract, 1.4 parts of licorice extract, 4 parts of polygonatum extract, 4 parts of agaricus blazei extract, 2 parts of chicken gizzard lining extract, 1.0 part of wolfberry extract, 0.9 part of cornus officinalis extract and 10 parts of arabinose.

4. A method for preparing the hypoglycemic composition containing edible leaves according to any one of claims 1 to 3, characterized in that: The following steps are involved:

1. Weighing ingredients: weigh the above raw materials in order according to the ratio; 2. Raw material pretreatment: crush the plant raw materials in sequence, mix them according to the proportion, and then use ethanol solution to extract them in a water bath twice, each time for 1-2 hours, and combine the extracts; 3. Concentration and drying: The extract is concentrated under reduced pressure to an extract form, and then spray-dried to obtain a powder; 4. Mixing and homogenizing: Mix the dry powder and arabinose according to the formula ratio, pass through a 75-85 mesh sieve, and homogenize for 25-35 minutes using a three-dimensional motion mixer to obtain a composition.

5. The method for preparing the hypoglycemic composition containing edible leaves according to claim 4, characterized in that: In the step 2, the raw material is crushed to 35-45 mesh, the volume fraction of the ethanol solution is 60%, the mass ratio of the raw material to the ethanol solution is 1:10, and the water bath temperature is 55-65°C.

6. The method for preparing the hypoglycemic composition containing edible leaves according to claim 4, characterized in that: In the step 3, the temperature of the reduced pressure concentration is 40-50°C, the vacuum degree is 0.06-0.1 MPa, the air inlet temperature is 170-190°C, and the air outlet temperature is 75-85°C.

7. A use of the blood sugar lowering composition containing edible leaves according to any one of claims 1 to 3, characterized in that: The composition is used for preparing blood sugar lowering functional food or medical health care product.